
MediciNova (MNOV) Earnings Dates & Reports
MediciNova (MNOV) Most Recent Earnings
Report DateMay 13, 2025
Period EndingQ1 2025
Est. EPS-$0.14
Actual EPS-$0.06
EarningsBeat
MediciNova (MNOV) Earnings
View the latest MediciNova (MNOV) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in MediciNova (MNOV)
Order type
Buy in
Order amount
Est. shares
0 shares
MediciNova (MNOV) Earnings per Share (EPS) History
Signup for full accessBrowse free
MediciNova (MNOV) Latest Earnings
The value each MNOV share was expected to gain vs. the value each share gained.
MediciNova (MNOV) reported its most recent earnings on May 13, 2025 for Q1 2025, posting earnings per share (EPS) of -$0.06. This exceeded analysts' expectations of -$0.14 by 57.14%, marking a Beat.
For comparison, MediciNova reported EPS of -$0.06 in the same quarter last year.
The company is expected to announce its next earnings report on 08/07/2025, with analysts projecting an EPS of $0.
MediciNova (MNOV) Earnings History
MediciNova (MNOV) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the MediciNova’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 13, 2025 | — | — | — |
Feb 19, 2025 | — | — | — |
Nov 13, 2024 | — | — | — |
Aug 8, 2024 | — | — | — |
MediciNova (MNOV) Earnings FAQs
MediciNova (MNOV) last reported earnings on May 13, 2025 for Q1 2025, posting an EPS of -$0.06, which Beat the estimate of -$0.14 by 57.14%.
For Q1 2025, MediciNova (MNOV) reported an EPS of -$0.06, exceeding analysts' estimate of -$0.14 by 57.14%.
For Q1 2025, MediciNova (MNOV) Beat expectations with an actual EPS of -$0.06 vs. an estimated EPS of -$0.14.
Following the last earnings report on May 13, 2025, MediciNova (MNOV)'s stock price moved — from — to —.
The next MediciNova (MNOV) earnings call is scheduled for Aug. 7, 2025, where executives will discuss financial results and outlook.